Brucella abortus strain RB51 can be used to express potentially protective antigens of Toxoplasma gondii.
Bandara
Abey B
AB
Department of Biomedical Sciences and Pathobiology, Center for Molecular Medicine and Infectious Diseases, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, 1410 Prices Fork Road, Blacksburg, VA 24061, USA.
Selem
Mohamad N
MN
Jordan
Carly N
CN
Lindsay
David S
DS
Shurig
Gerhardt G
GG
Sriranganathan
Nammalwar
N
D000818:Animals; D000953:Antigens, Protozoan / Q000235:genetics*; D001428:Bacterial Vaccines / Q000235:genetics*; D002003:Brucella abortus / Q000235:genetics*; D015870:Gene Expression; D005822:Genetic Vectors / Q000235:genetics*; D015800:Protozoan Proteins / Q000235:genetics; D014122:Toxoplasma / Q000235:genetics / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000235:genetics
D000953:Antigens, Protozoan; D001428:Bacterial Vaccines; C095047:GRA6 protein, Toxoplasma gondii; C106990:Gra2 protein, Toxoplasma gondii; D015800:Protozoan Proteins; D014614:Vaccines, Synthetic; C067547:surface antigen P22, Toxoplasma